[Lymphomas in children infected with HIV-1] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Lymphomas in children infected with HIV-1]

Arch Pediatr. 2000 Jul;7(7):738-44. Unique Identifier : AIDSLINE MED/20397084
Gandemer V; Verkarre V; Quartier P; Brousse N; Blanche S; Unite d'immunologie-hematologie pediatrique, hopital; Necker-Enfants-malades, Paris, France.


Abstract: PURPOSE: To describe the features of lymphoma in human immunodeficiency virus (HIV)-infected children, their treatments and the outcome of patients. RESULTS: We analyzed seven HIV-infected children (four by mother-to-child transmission and three by transfusion) (25 months to 18.5 years old) with lymphoma (one Hodgkin's disease and six non-Hodgkin's lymphomas). All of them presented with a severe immunodepression and a high viral load. Five of six were high grade-B cell non-Hodgkin's lymphoma of large-cell histologies (immunoblastic or centroblastic). Five were extranodular disease and three were metastatic at diagnosis. Epstein-Barr virus was detected in four tumors. Five of seven received a multiagent chemotherapy. Toxicity was high. Treatment for the skin T lymphoma consisted of radiation therapy. Five children were complete responders (with survival three years, 2.5 years, 12, 18 and 18 months) and two died of progression of lymphoma (four and five months later). CONCLUSION: Incidence of lymphoma is increased in HIV-infected children. Anticancer chemotherapy regimens that include aggressive supportive care and concomitant antiretroviral therapy or immunotherapy may yield high survival rates.


Keywords: JOURNAL ARTICLE Adolescence Antineoplastic Agents, Combined/THERAPEUTIC USE Child Child, Preschool English Abstract Female Human HIV Infections/*COMPLICATIONS HIV-1 Immunotherapy Lymphoma, AIDS-Related/IMMUNOLOGY/PATHOLOGY/*THERAPY Male Prognosis Survival Analysis

KWDjournalarticleadolescenceantineoplasticagents,combined/therapeuticusechildchild,preschoolenglishabstractfemalehumanhivinfections/KWDcomplicationshiv-1immunotherapylymphoma,aids-related/immunology/pathology/KWDtherapymaleprognosissurvivalanalysis
001230
A00C0926


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .